trial · primary record
Cyclophosphamide
Severe Aplastic Anemia (SAA)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 56 |
| Primary completion | 2028-06-01 |
| Primary endpoint | Evaluate 1 year chronic GVHD-free survival rate |
| Registry ID | NCT03520647 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:38.571Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03520647
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Cyclophosphamide · approval
- Cyclophosphamide · compound